Asia’s Leading Plant Based Biotechnology Company

With the world edging towards aging society, we believe that the solution to global health lies in high quality plant-based biotechnology. Our team constantly researches the wide library of herbs and plants, with thousands years of tradition, to find the most effective compounds to cure various illnesses and improve health.

Thailand is often called the “Amazon of Asia” with a large pool of biodiversity, being centrally located with India to the West, China to the North East, and Indonesia to the South. With our advanced extraction, purification, and formulation technologies, we are able to bring the best of these products to the global markets.

We are fully vertically integrated from cultivation, to extraction, product formulation, and sales and distribution, with full certifications and licenses such as GACP, GMP, GMP PIC/S, ISO9001, ISO17025, amongst others. Our current product portfolio includes high potency extracts from cannabis (cannabinoids), and other plants (alkaloids).

Biotechnology Innovations

PACCAN’s Mitragynine Water Soluble

Through our proprietary extraction and processing method, we are excited to present our 80-85% mitragynine solution extracted from Thai kratom biomass, and is formulated to be water soluble.

Click on the image to be redirected to a full mitragynine extract page where you can find full information on COA, safety, and video presentation of the product.

Presenting our new compound positioned for cosmetic application: ZINC CBD

ZINC is widely used as a key ingredient in sun screen and sun block products as it presents a high Sun Protection Factor (SPF) level. SPFs with zinc oxide or titanium dioxide are considered mineral sunscreens. Currently, the FDA has concluded that zinc oxide and titanium dioxide are the only two sunscreen actives that are safe and effective.

At PACCAN we have infused CBD together with our ZINC isolate, creating a ground breaking proprietary compound that protects skin from sun exposure AND simultaneously nourishes the skin through CBD anti-inflamatory properties. ZINC CBD will help directly reduce damages from sunburn such as skin burn and skin peeling. We are ready to collaborate with cosmetic companies that want to develop these lines of innovative skin care products.

PACCAN’s Medical Doctor Team

  • Dr. Isara Chiawiriyabunya, MD

    Ex Director of Udonthani Cancer Hospital, one of the founding leaders of Thailand’s medical cannabis industry, with his own first Thailand-registered cannabis strain called “Isara 01”

  • Dr. Sakda Charnvanichayachai, MD, Surgeon

    Herbal medical specialist; Dr. Sakda has deep experiences in application of various plant based biotech products for treatments of insomnia, chronic pain, Parkinson, and others. He also houses knowledge of Thai traditional herbal medication, and stem cell treatment.

  • Dr Chanin Leewanun, MD

    Medical cannabis specialist, Dr Chanin has more than 5 years of experience with traditional Thai medical product applications. In addition, he is one of the early adopters and advocates of medical cannabis wholistic treatment.

  • Dr. Sitthisak Dhammawiwatnukul, MD

    Alternative medicine specialist. Dr Sittisak has a wealth of experience in alternative medicine and wellness treatments, including stem cell treatments, DNA mapping, and vitamin infusion treatments. He is a resident Doctor at BRM in Bangkok.

PACCAN’s Medical Development

On the 29th of November, 2022, Pacific Cannovation donates 500,000 THB worth of D.R. Cann medical cannabis medicine to Udonthani Cancer Hospital, under Department of Medical Services, Ministry of Public Health. This is part of our ongoing efforts to support the government to further research and developments of medical cannabis application and clinical trial research. The donated formulations include CBD, CBN, CBG, CBD: CBN, and CBD: CBG. We are proud to play a part in supporting Thailand’s rising medical cannabis industry. Much more to come!

On the 17th of August, 2022, Pacific Cannovation Company Limited signed an Memorandum of Agreement with the Department of Medical Services/ Udonthani Cancer Hospital.

The MOA is for the joint collaboration in research and development, production, and manufacturing of medical cannabis products for commercial purposes, with the aim to further enhance patient care.